TY - JOUR AB - Transketolase genes are key rate‑limiting enzymes in the non‑oxidative part of the pentose phosphate pathway, which is an important metabolic pathway in ribose‑5‑phosphate production. Three human transketolase genes have been identified: Transketolase (TKT), transketolase‑like gene 1 (TKTL1) and transketolase‑like gene 2 (TKTL2). Transketolase genes serve crucial roles in the tumorigenesis, metastasis and outcome of multiple types of cancer. However, the expression levels and prognostic values of transketolase family genes in patients with ovarian cancer remain unclear. The purpose of the study was to analyze the expression level and prognostic significance of transketolase family genes in ovarian cancer. In the present study, the mRNA expression levels of three transketolase genes in ovarian cancer and normal ovarian tissue were compared by Oncomine. The prognostic values of these genes were systemically assessed using the Kaplan‑Meier plotter database. In addition, the associations between the mRNA levels of these transketolase genes and the clinicopathological characteristics of patients with ovarian cancer, such as histological subtype, clinical stage, grade, tumor protein p53 (TP53) mutation status and chemotherapy history were studied. The prognostic roles of transketolase genes were also evaluated in a validation dataset. The results demonstrated that TKT and TKTL1 expression in ovarian cancer tissues was elevated compared with that in normal ovarian tissues. In addition, high mRNA expression of the three transketolase genes was identified to be associated with poorer progression‑free survival (PFS) in patients with serous ovarian cancer, especially in patients at an advanced stage. TKTL2 was significantly associated with poor overall survival in all patients with ovarian cancer. Additionally, transketolase family genes served a role in predicting PFS in patients with ovarian cancer treated with platinum and/or taxol. High expression of the three transketolase genes was associated with unfavorable PFS in patients with TP53‑mutated ovarian cancer, but not in patients with TP53 wild‑type ovarian cancer. These results suggested that transketolase family genes may serve important roles in the prognosis of patients with ovarian cancer. AD - Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China AU - Zhao,Menghuang AU - Ye,Miaomiao AU - Zhou,Junhan AU - Zhu,Xueqiong DA - 2019/11/01 DO - 10.3892/ol.2019.10818 EP - 4857 IS - 5 JO - Oncol Lett KW - ovarian cancer transketolase prognosis Kaplan‑Meier plotter expression PY - 2019 SN - 1792-1074 1792-1082 SP - 4845 ST - Prognostic values of transketolase family genes in ovarian cancer T2 - Oncology Letters TI - Prognostic values of transketolase family genes in ovarian cancer UR - https://doi.org/10.3892/ol.2019.10818 VL - 18 ER -